首页> 外文期刊>Comparative biochemistry and physiology. Toxicology & pharmacology: CBP >Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis
【24h】

Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis

机译:对马褐蛙林蛙林皮肤中的抗菌肽

获取原文
获取原文并翻译 | 示例
           

摘要

The Tsushima brown frog Rana tsushimensis Stejneger, 1907 exists in reproductive isolation on the island of Tsushima, Japan. Six peptides with antimicrobial activity were isolated in pure form from an extract of the skin of this species and their amino acid sequences identified them as members of the brevinin-1 (one peptide), brevinin-2 (one peptide) and temporin (four peptides) families. The C-terminally a-amidated brevinin-1 peptide (FLGSIVGALASALPSLISKIRN.NH2) lacks the cyclic heptapeptide domain Cys(18)-(Xaa)(4)-Lys-Cys(24) at the COOH-terminus of the molecule that characterizes other members of that family. A structurally similar brevinin-1 peptide, also lacking the cyclic domain, was previously isolated from the skin of the Ryukyu brown frog Rana okinavana, indicative of a close phylogenetic relationship between the species. Brevinin-2TSa (GIMSLFKGVLKTAGKHVAGSLVDQLKCKITGGC) showed broad-spectrum growth inhibitory activity against a range of Gram-negative and Gram-positive bacteria (including methicillin-resistant Staphylococcus aureus) (minimum inhibitory concentrations <= 25 mu M) and relatively low hemolytic activity against human erythrocytes (LD50=100 mu M). The peptide therefore represents a candidate for drug development. (c) 2005 Elsevier Inc. All rights reserved.
机译:对马棕蛙蛙林蛙(Rana tsushimensis Stejneger,1907)在日本对马岛的繁殖隔离中生存。从该物种的皮肤提取物中以纯净形式分离出六种具有抗菌活性的肽,其氨基酸序列将其鉴定为brevinin-1(一种肽),brevinin-2(一种肽)和temporin(四种肽)的成员。 ) 家庭。 C端a-酰胺化的brevinin-1肽(FLGSIVGALASALPSLISKIRN.NH2)在该分子的COOH末端缺少环状七肽结构域Cys(18)-(Xaa)(4)-Lys-Cys(24)那个家庭的成员。先前从琉球棕色青蛙蛙蛙皮的皮肤中分离出结构上相似的也缺乏环状结构域的brevinin-1肽,这表明该物种之间存在着密切的系统发育关系。 Brevinin-2TSa(GIMSLFKGVLKTAGKHVAGSLVDQLKCKITGGC)对多种革兰氏阴性和革兰氏阳性细菌(包括耐甲氧西林的金黄色葡萄球菌)(最低抑菌浓度<= 25μM)(对人体的最低抑菌浓度)表现出广谱抑制活性,对人的溶血活性相对较低红细胞(LD50 = 100μM)。因此,该肽代表药物开发的候选物。 (c)2005 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号